BANK VONTOBEL/CALL/NOVO NORDISK ADR B/94/0.1/20.09.24 Share Price

Warrant

DE000VM4Q9G1

Delayed Deutsche Boerse AG 01:44:54 02/07/2024 pm IST
4.9 EUR -0.41% Intraday chart for BANK VONTOBEL/CALL/NOVO NORDISK ADR B/94/0.1/20.09.24
Current month+3.58%
1 month+28.12%
Date Price Change
02/24/02 4.9 -0.41%
01/24/01 4.92 +3.58%
28/24/28 4.75 -1.25%
27/24/27 4.81 +0.63%
26/24/26 4.78 -5.35%

Delayed Quote Deutsche Boerse AG

Last update July 02, 2024 at 01:44 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VM4Q9G
ISINDE000VM4Q9G1
Date issued 27/10/2023
Strike 94 $
Maturity 20/09/2024 (81 Days)
Parity 10 : 1
Emission price 1.39
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.13
Lowest since issue 1.22
Delta0x
Omega 0.000000
Premium0x
Gearing2.78x
Moneyness 1.547
Difference Strike -51.42 $
Difference Strike %-54.70%
Spread 0.03
Spread %0.61%
Intrinsic value 4.796

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,005 DKK
Average target price
950.4 DKK
Spread / Average Target
-5.39%
Consensus